Showing 1 - 10 of 8,027
Persistent link: https://www.econbiz.de/10012957025
Today, the global pharmaceutical product value chain is becoming increasingly complex and this has led to the emergence of 'multiple quality standards' for medicines. But this non-uniformity in the quality of medicine is also contingent upon both the regulatory milieu in the country of...
Persistent link: https://www.econbiz.de/10011337690
Persistent link: https://www.econbiz.de/10011456704
Persistent link: https://www.econbiz.de/10012596763
Background: Active Pharmaceutical Ingredient (API) manufacturing is an important segment of the Indian pharma industry. India ranks third in terms of volume of medicines produced, and is a major global supplier of generic medicines. However, India depends heavily on the import of several raw...
Persistent link: https://www.econbiz.de/10012547902
Persistent link: https://www.econbiz.de/10014461499
China and India which resulted in differential levels of gain in health indicators. An attempt has been made to synthesize …
Persistent link: https://www.econbiz.de/10014197238
The global pharmaceutical industry is in an era of greater uncertainty because of looming patent expiries of established drugs having a direct impact on their sales and profitability. Further discovering new drugs in-house is a risky, time consuming and expensive proposition. This has forced...
Persistent link: https://www.econbiz.de/10012994958
Persistent link: https://www.econbiz.de/10012512495
Persistent link: https://www.econbiz.de/10012254375